1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow insulin glargine recombinant: new trials by email Literature Review of insulin glargine recombinant trials Research Report on insulin glargine recombinant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia insulin glargine recombinant, therapeutic insulin - Hyperglycemia, Leukemia | Phase 3 | Withdrawn | University of Medicine and Dentistry of New Jersey | 2009-05-01 | 2013-08-30 |
Congenital Abnormalities (1) · Hyperglycemia (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
University of Medicine and Dentistry of New Jersey (1)
United States (1)
P30CA072720 (1)